266 related articles for article (PubMed ID: 23647840)
1. Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers.
Parisé H; Laliberté F; Lefebvre P; Duh MS; Kim E; Agashivala N; Abouzaid S; Weinstock-Guttman B
J Neurol Sci; 2013 Jul; 330(1-2):71-7. PubMed ID: 23647840
[TBL] [Abstract][Full Text] [Related]
2. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
3. Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US.
Ivanova JI; Bergman RE; Birnbaum HG; Phillips AL; Stewart M; Meletiche DM
J Med Econ; 2012; 15(3):601-9. PubMed ID: 22376190
[TBL] [Abstract][Full Text] [Related]
4. Economic costs associated with an MS relapse.
O'Connell K; Kelly SB; Fogarty E; Duggan M; Buckley L; Hutchinson M; McGuigan C; Tubridy N
Mult Scler Relat Disord; 2014 Nov; 3(6):678-83. PubMed ID: 25891546
[TBL] [Abstract][Full Text] [Related]
5. Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.
Karampampa K; Gustavsson A; van Munster ET; Hupperts RM; Sanders EA; Mostert J; Sinnige OL; de Graaf J; Pop P; Miltenburger C; Groot MT; Relleke M; van der Hel WS
J Med Econ; 2013 Jul; 16(7):939-50. PubMed ID: 23692584
[TBL] [Abstract][Full Text] [Related]
6. Costs and quality of life in multiple sclerosis patients with spasticity.
Svensson J; Borg S; Nilsson P
Acta Neurol Scand; 2014 Jan; 129(1):13-20. PubMed ID: 23683163
[TBL] [Abstract][Full Text] [Related]
7. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
10. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
11. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
[TBL] [Abstract][Full Text] [Related]
12. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
13. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
[TBL] [Abstract][Full Text] [Related]
14. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
15. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
16. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Karampampa K; Gustavsson A; Miltenburger C; Eckert B
Mult Scler; 2012 Jun; 18(2 Suppl):7-15. PubMed ID: 22623122
[TBL] [Abstract][Full Text] [Related]
17. Cost of multiple sclerosis in the Czech Republic: the COMS study.
Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
[TBL] [Abstract][Full Text] [Related]
18. Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment.
Lage MJ; Carroll CA; Fairman KA
J Med Econ; 2013 Sep; 16(9):1146-53. PubMed ID: 23844620
[TBL] [Abstract][Full Text] [Related]
19. Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis.
Rivera-Navarro J; Benito-León J; Oreja-Guevara C; Pardo J; Dib WB; Orts E; Belló M;
Mult Scler; 2009 Nov; 15(11):1347-55. PubMed ID: 19797453
[TBL] [Abstract][Full Text] [Related]
20. Societal costs of multiple sclerosis in Ireland.
Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
